Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome

NCT00000627 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Histoplasmosis

Interventions

DRUG: Fluconazole

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]